Abstract
Seven of nine depressed patients experienced a 4.3-fold increase in rated euphoria and activation following 30 mg d-amphetamine in a replicated dose, double blind study. d-Amphetamine was 2 to 2.3-fold more effective in producing activation, euphoria, and antidepressant effects than the same dose of l-amphetamine.
Co-treatment with lithium carbonate produced a 60% (P<0.001) attenuation of the activation and euphoria responses to d-amphetamine. The responses to l-amphetamine were almost completely abolished by lithium. This study raises the possibility of lithium carbonate use as an adjunct in the treatment of amphetamine addiction.
Similar content being viewed by others
References
Alles, G. A.: Comparative actions of optically isomeric phenisopropylamines. J. Pharmacol. exp. Ther. 66, 1 (1939)
Angrist, B. M., Gershon, S.: The phenomenology of experimentally induced psychosis. Preliminary observations. Biol. Psychiat. 2, 95 (1970)
Asatoor, A. M., Galman, B. R., Johnson, J. R., Milne, M. D.: The excretion of dexamphetamine and its derivatives. Brit. J. Pharmacol. 24, 293–300 (1965)
Beckett, A. H., Salmon, J. A., Mitchard, M.: The relation between blood levels and urinary excretion of amphetamine under controlled acidic and under fluctuating urinary pH values using [14C]amphetamine. J. Pharm. Pharmacol. 21, 251–258 (1969)
Beigel, A., Murphy, D. L., Bunney, W. E., Jr.: The manicstate rating scale. Arch. gen. Psychiat. 25, 256–262 (1971)
Bunney, B. S., Walters, J. R., Kuhar, M. J., Roth, R. H., Aghajanian, G. K.: d- and l-amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons. Psychopharmacol. Commun. 1, 177–190 (1975)
Bunney, W. E., Jr., Hamburg, D. A.: Methods for reliable longitudinal observation of behavior. Arch. gen. Psychiat. 9, 280–294 (1963)
Carroll, B. J., Sharp, P. T.: Rubidium and lithium: Opposite effects on amine-mediated excitement. Science 172, 1355–1357 (1971)
Cassens, G. P., Mills, A. W.: Lithium and amphetamine: opposite effects on threshold of intracranial reinforcement. Psychopharmacologia (Berl.) 30, 283–290 (1973)
Connell, P. H.: Clinical manifestations and treatment of amphetamine type of dependence. J. Amer. med. Ass. 196, 718–723 (1966)
Cox, C., Harrison-Read, P. E., Steinberg, H., Tomkiewicz, M.: Lithium attenuates drug-induced hyperactivity in rats. Nature (Lond.) 232, 336–338 (1971)
Davies, C., Sanger, D. J., Steinberg, H., Tomkiewicz, M., U'Prichard, D. C.: Lithium and α-methyl-p-tyrosine prevent “manic” activity in rodents. Psychopharmacologia (Berl.) 36, 263–274 (1974)
Davis, J. M., Janowsky, D. S.: Amphetamine and methylphenidate psychosis. In: Frontiers in catecholamine research, E. Usdin and S. Snyder, eds., pp. 977–981. New York: Pergamon Press 1973
Davis, J. M., Kopin, I. J., Lemberger, L., Axelrod, J.: Effects of urinary pH on amphetamine metabolism. Ann. N.Y. Acad. Sci. 179, 493–501 (1971).
D'Encarnacao, P. S., Anderson, K.: Effects of lithium pre-treatment on amphetamine and DMI tetrabenazine produced psychomotor behavior. Dis. nerv. Syst. 31, 494–496 (1970)
Fawcett, J., Maas, J. W.: Depression and MHPG excretion. Response to dextroamphetamine and tricylic antidepressants. Arch. gen. Psychiat. 26, 246–251 (1972)
Flemenbaum, A.: Does lithium block the effects of amphetamine? A report of three cases. Amer. J. Psychiat. 131, 7 (1974)
Gershon, S., Shopsin, B.: Lithium. New York: Plenum Press 1973
Gillin, J. C., van Kammen, D. P., Graves, J., Murphy, D. L.: Differential effects of d- and l-amphetamine on the sleep of depressed patients. Life Sciences (in press, 1975)
Goodwin, F. K., Murphy, D. L., Bunney, W. E., Jr.: Lithium carbonate in depression and mania: A longitudinal double-blind study. Arch. gen. Psychiat. 21, 486–496 (1969)
Griffith, J. D., Cavanaugh, J., Held, J., Oates, J. A.: Dextroamphetamine. Evaluation of psychomimetic properties in man. Arch. gen. Psychiat. 26, 97–100 (1972)
Henry, G., Buchsbaum, M., Murphy, D. L.: Intravenous l-Dopa plus carbidopa in depressed patients: Average evoked response, learning and behavior changes. Psychosom. Med. (in press)
Innes, I. R., Nickerson, M.: In: The pharmacological basis of therapeutics, L. S. Goodman and A. Gilman, eds., pp. 502–504, 1970
Jonsson, L.-E., Anggard, E., Gunne, L.-M.: Blockade of intravenous amphetamine euphoria in man. Clin. Pharmacol. Ther. 12, 889–896 (1971)
Kramer, J. C., Fishman, V. S., Littlefield, D. C.: Amphetamine abuse. Pattern and effects of high doses taken intravenously. J. Amer. med. Ass. 201, 305–309 (1967)
Kreuz, D. S., Axelrod, J.: Amphetamine in human plasma: A sensitive and specific enzymatic assay. Science 183, 420–421 (1974)
Lal, S., Sourkes, T. L.: Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents. Arch. int. Pharmacodyn. 199, 289–301 (1972)
Maas, J. W., Fawcett, J. A., Dekirmenjian, H.: Catecholamine metabolism, depressive illness, and drug response. Arch. gen. Psychiat. 26, 252–262 (1972)
Matussek, N., Linsmayer, M.: The effect of lithium and amphetamine on desmethylimipramine-RO 4-1284 induced motor hyperactivity. Life Sci. 7, 371–375 (1968)
Menon, M. K., Dandiya, P. C., Bapna, J. S.: Modification of the effect of some central stimulants in mice pretreated with α-methyl-l-tyrosine. Psychopharmacologia (Berl.) 10, 437–444 (1967)
Murphy, D. L.: l-Dopa, behavioral activation and psychopathology. In: Neurotransmitters, Res. Publ. A.R.N.M.D., Vol. 50, I. J. Kopin, ed., pp. 472–493, 1972
Murphy, D. L., Colburn, R. W., Davis, J. M., Bunney, W. E., Jr.: Imipramine and lithium effects on biogenic amine transport. Amer. J. Psychiat. 127, 339–345 (1970)
Murphy, D. L., Redmond, D. E.: The catecholamines: possible role in affect, mood and emotional behavior in man and animals. In: Catecholamines and behavior, A. J. Friedhoff, ed. pp. 73–117. New York: Plenum Press 1975
Murphy, D. L., Donnelly, C., Moskowitz, J.: Inhibition by lithium of prostaglandin E1 and norepinephrine effects on cyclic adenosine monophosphate production in human platelets. Clin. Pharmacol. Ther. 14, 810–814 (1973)
Prinzmetal, M., Alles, G. A.: The central nervous system stimulant effects of dextro amphetamine sulphate. Amer. J. med. Sci. 20, 665–673 (1940)
Randrup, A., Munkvad, I.: Dopa and other naturally occurring substances as causes of stereotypy and rage in rats. Acta psychiat. scand., Suppl. 191, 193–199 (1966)
Schildkraut, J. J.: Pharmacology — The effects of lithium on biogenic amines. In: Lithium, S. Gershon and B. Shopsin, eds., pp. 51–74. New York: Plenum Press 1973
Schildkraut, J. J., Kety, S. S.: Biogenic amines and emotion. Science 156, 21–30 (1967)
Schou, M.: Lithium in psychiatric therapy and prophylaxis. J. psychiat. Res. 6, 67–95 (1968)
Snyder, S. H.: Catecholamines in the brain as mediators of amphetamine psychosis. Arch. gen. Psychiat. 27, 169–179 (1972)
Stein, L., Wise, C. I.: Amphetamine and noradrenergic reward pathways. In: Frontiers in catecholamine research, E. Usdin and S. H. Snyder, eds., pp. 963–968. New York: Pergamon Press 1973
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Kammen, D.P., Murphy, D.L. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 44, 215–224 (1975). https://doi.org/10.1007/BF00428897
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00428897